94242-04-3

Basic information

• Product Name: 1,3-benzoxazol-7-ol
• Synonyms: 1,3-benzoxazol-7-ol;Benzo[d]oxazol-7-ol
• CAS NO: 94242-04-3
• Molecular Formula: C7H5NO2
• Molecular Weight: 135.1201
• Mol File: 94242-04-3.mol

Chemical Properties

• Boiling Point: 270.0±13.0 °C(Predicted)
• Appearance: /
• Density: 1.378±0.06 g/cm3(Predicted)
• PKA: 7.75±0.40(Predicted)
• CAS DataBase Reference: 1,3-benzoxazol-7-ol(CAS DataBase Reference)
• NIST Chemistry Reference: 1,3-benzoxazol-7-ol(94242-04-3)
• EPA Substance Registry System: 1,3-benzoxazol-7-ol(94242-04-3)

Safety Data

• Hazardous Substances Data: 94242-04-3(Hazardous Substances Data)

Usage

Uses

Used in Traditional Medicine:
1,3-Benzoxazol-7-ol is used as a therapeutic agent for its anti-inflammatory, antioxidant, and anti-cancer properties, making it a valuable component in traditional medicine for treating various ailments.
Used in the Food Industry:
1,3-Benzoxazol-7-ol is used as a flavoring agent in the food industry, contributing to the taste and aroma of various food products.
Used in Biochemical Assays:
1,3-Benzoxazol-7-ol is used as a fluorescent dye in biochemical assays, aiding in the visualization and analysis of biological processes and molecules.
Used in Pharmaceutical Research:
1,3-Benzoxazol-7-ol is used as a subject of pharmacological research for its potential to inhibit platelet aggregation and as a possible treatment for Parkinson's disease, indicating its potential in developing new drugs and therapies.

Upstream product

• 20734-66-1 1,2-dihydroxy-3-aminobenzene 
• 122-51-0 orthoformic acid triethyl ester 

Relevant articles and documents

Method for synthesizing benzoxazole through microwave radiation of benzamide compound in water phase

The invention discloses a method for synthesizing benzoxazole through microwave radiation of a benzamide compound in a water phase. The benzamide compound is added into the water phase under the microwave condition to be subjected to a cyclization reaction for generating the benzoxazole under the alkali condition, and the method for preparing the benzoxazole is environmentally friendly, easy and convenient to operate, safe, low in cost and efficient. Compared with the prior art, the method can be applied to a large number of functional groups, the yield is high, the number of by-products is small, and the method is easy to operate, safe, low in cost and environmentally friendly. (Please see the specifications for the formula).

COMPOUND HAVING ZNF143 INHIBITORY ACTIVITY AND USE THEREOF

PROBLEM TO BE SOLVED: To provide a compound having a ZNF143 inhibitory activity as well as to provide a ZNF143 inhibitory agent and pharmaceutical composition containing the same. SOLUTION: Provided is a compound represented by formula (I) or a salt thereof as well as a ZNF143 inhibitory agent containing the same and a pharmaceutical composition having the same as an active ingredient. A-B-C-D (I)[A is H, a methyl group, a naphthyl group, a phenyl group or a nitrogen-containing heterocyclic ring; B is as shown below, and C is an amide bond or a heteroaromatic ring containing N and O; D is a substituted/unsubstituted phenyl group or a monocyclic heteroaromatic ring containing N or S; and C and D are both fused heterocyclic ring or the like optionally having a substituent group.]. SELECTED DRAWING: Figure 1 COPYRIGHT: (C)2016,JPOandINPIT

Benzofuranyl carbamates

Compounds of the structure; STR1 and pharmaceutically acceptable salts thereof, wherein: R1 is H, alkyl, alkoxy, carboxyl, alkylcarboxy, trifluoromethyl, halogen, nitro or hydroxy; X is O, N, S or C; Y is O, N or S; and R2 is H, alkyl, cycloalkyl, aryl or heteroaryl useful in the treatment of ischemic heart disease and hypertriglyceridemia.